Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra is Needed for Successful Control of DR-TB in Southern Mozambique

Clin Infect Dis. 2024 Apr 10;78(4):842-845. doi: 10.1093/cid/ciad684.

Abstract

Multidrug-resistant(MDR) tuberculosis in Southern Africa is of great concern, exacerbated by the spread of a clone harboring a mutation missed by Xpert Ultra. In Southern Mozambique, the presence of such mutation and rising cases of non-MDR isoniazid resistance highlights the need to ensure accurate detection of antimicrobial-resistance in the country.

Keywords: Mycobacterium tuberculosis; Mozambique; resistance conferring mutations; whole-genome sequencing.

MeSH terms

  • Drug Resistance, Bacterial / genetics
  • Humans
  • Mozambique
  • Mutation
  • Mycobacterium tuberculosis* / genetics
  • Rifampin / pharmacology
  • Rifampin / therapeutic use
  • Sensitivity and Specificity
  • Tuberculosis, Multidrug-Resistant* / diagnosis
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Rifampin

Grants and funding